Rivka Riven Kreitman, Phd — investor profile photo

Rivka Riven Kreitman, Phd

Senior Partner, KRDable Consulting and Scientific Co-Founder, Neuralight.ai

📍 Ambler, Pennsylvania, United States🔄 Updated November 2026💼 3 investments📅 18 years investing🗓 Last invested Sep 2018
VC🌍 United States
3
Total investments
0
Early stage
0
Mid stage
0
Late stage
18y
Years active

Portfolio

0 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
No investments found
Experience · 6 entries
All (6)
Investments (3)
Founder (1)
Board (3)
2024
Scientific Co-Founder
May 2024
NeuraLight is a healthtech company on a mission to make brain function accurately measurable and actionable. Fusing decades of world-class neuroscience research with a breakthrough AI engine and proprietary data, the NeuraLight platform sets a new standard by quantifying core aspects of brain function at scale. NeuraLight’s technology is embedded in multiple commercial partnerships and endorsed by leading neurologists, Nobel laureates, and major research foundations, establishing it as prominent infrastructure for the future of brain health
2019
Scientific Advisory Board
Feb 2019
Sanara is a unique Israeli health-tech investment platform that focused on three main verticals: digital-health, bio-convergence and medical devices. Sanara consists of two investment vehicles, Sanara Ventures and Sanara Capital. Sanara Ventures is a seed-stage investment incubator-fund, supported by Philips and Teva Pharmaceuticals, and has 18 active startup companies on its portfolio. Sanara Capital, is an A-B round venture capital, that is doing follow-on investment to the best companies coming out of Sanara Ventures, as well as A-B round investments in external, non-Sanara related companies.
2018
KRDable Consulting
Senior Partner
Dec 2018
BrainBoost- by Segol School of Neuroscience-TAU
Board Member
Sep 2018
2008
PICC- Philadelphia Israel Chamber of Commerce
Board Member
2008
Show all 6 entries ↓
Investment activity
2008–2018 · 3 investments
2008220181
Recent (last 2 years)Earlier
Investor lists
Lists that match Rivka's portfolio